Sands Capital Alternatives, LLC / Sands Capital
Sands Capital closes Global Innovation Fund III at $1.1 billion
Summary: Sands Capital announced the close of Global Innovation Fund III at $1.1 billion. The verified source is a press-release republication recovered through reader checks and mapped to Sands Capital Alternatives / Sands Capital filing context.
Why it matters: The update may matter as a private-fund capital-formation signal for a growth-oriented technology platform, while filing context should be used only for identity and scale background, not as proof of the close or performance.
Summary
Sands Capital announced the close of Global Innovation Fund III at $1.1 billion. The source reviewed for this draft is a Seeking Alpha press-release republication, with the verifier confirming that the event is distinct from the already published Sands/Brightflag update.
This item is scoped to Sands Capital Alternatives / Sands Capital and the Global Innovation Fund III fund family. The public filing context helps confirm the adviser and fund-family identity, but it should not be used to independently validate the announced close or to infer investment results.
Why it matters
For due-diligence readers, the fund close is relevant as a capital-formation and strategy-capacity signal for a manager associated with growth and innovation investing. It can help frame follow-up questions about fund structure, portfolio-construction approach, public/private exposure, and how the manager describes its opportunity set.
The announcement is not an assessment of the fund’s performance, suitability, or future deployment success.
Source notes
- Press-release republication: https://seekingalpha.com/pr/20440399-sands-capital-closes-oversubscribed-global-innovation-fund-iii
- Public adviser profile: https://adviserinfo.sec.gov/firm/summary/155517
- Verifier note: draft under Sands Capital Alternatives / Global Innovation Fund III framing; do not imply the separate Sands Brightflag/Global Ventures exit post covered this event.
9AT filing context
Public ADV/profile context maps Sands Capital Alternatives, LLC to CIK 1846444, CRD 155517 / SEC file 801-72115, with about $5.4 billion in reported regulatory AUM/profile scale. The profile output shows 182 employees, 52 private funds, no separately managed account flag, and public websites/domains sandscapitalventures.com and sandscapital.com.
The private-fund profile includes Sands Capital Global Innovation Fund III, L.P. and related Fund III variants. Those rows support the fund-family naming link, but they should not be added together or treated as a reconciliation to the announced $1.1 billion close unless a public source explicitly explains the structure.
Sands Capital Alternatives filed a public Form 13F-HR for period 2026-03-31 on 2026-05-08, with 21 listed information-table rows and parsed value total of about $421.2 million. The largest returned rows by parsed value included Nu Holdings, Klaviyo, Spyglass Pharma, Beta Bionics, Inhibikase Therapeutics, Coupang, Samsara, and DoorDash. The 13F is a delayed public-equity snapshot and is not a view into Global Innovation Fund III’s private-company exposure or performance.
What to watch
Watch for Sands-authored fund materials, Form ADV updates, future portfolio-company announcements, and any public explanations of how the Global Innovation Fund III vehicle structure, strategy focus, and deployment cadence are described by the manager.